特瑞普利单抗联合AP方案一线治疗手术不可切除的局部晚期非小细胞肺癌研究
A study on toripalimab combined with AP regimen as first-line treatment for surgically unresectable locally advanced non-small cell lung cancer
DING Wenjin， HOU Jianping， ZHANG Qi， LIU Jiarong(DepartmentofOncology，General Hospital of PingmeiShenma Group，Pingdingshan 467ooo，Henan，China)
【Abstract】ObjectiveToobservetheeficacyof toripalimabcombinedwithAPregimen inthetreatmentofunresectable locallyadvanced non-smallcellung cancer (LA-NSCLC).MethodsAtotalof 30patients with uresectable LA-NSCLC who received AP regimen chemotherapy + conventional radiotherapy from October 2022 to May 2O23 were enrolled as control group，while 32 patients who received toripalimab + AP regimen chemotherapy + conventional radiotherapy during the same period were included inobservationgroup.The treatment wascontinued for4cycles.After treatment ......
您现在查看是摘要页，全文长 16200 字符。